|
Oxford Immune Algorithmics (OIA) is very proud to have partnered with the University of Reading and welcomes two of their students in Computer Science hired with the partial support of the University of Reading internship scheme and grant. OIA is engaged with the local community and the young people of Reading where OIA's headquarters are located.  We are very excited to share the announcement that we have accomplished a major milestone getting Algocyte® certified under the European Commission medical device directive. Algocyte® is OIA's flagship product, an end-to-end app and solution for remote blood testing and health monitoring based on our proprietary technology (two patents pending no. 1918950.5 and 1918948.9 (UK)).
OIA will be exhibiting at one of the world’s leading summits on AI in medicine, Intelligent Health 2020 on 5 February 2020 at a prime venue, the ExCel, London, U.K. where we will be promoting Algocyte, our flagship product for end-to-end remote blood testing and health monitoring.   |
RSS Feed
A 50 game-changers company
Copyright © 2020
Oxford Immune Algorithmics
Oxford Immune Algorithmics